Fountain Biopharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 39

Employees

  • Latest Deal Type
  • PIPE

  • Financing Rounds
  • 3

  • Investments
  • 1

Fountain Biopharma General Information

Description

Fountain Biopharma Inc is engaged in the development of antibody drugs in Taiwan. It's pipeline products include antibody drugs for cancer, asthma and allergic diseases, and Chinese hamster ovary cell production. The company is focused on the development of therapeutic monoclonal antibodies and DNA aptamers for cancer and immunological conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporation
Corporate Office
  • 19-1, Number 3 Yuan Qu Street
  • Nankang District
  • Taiepi, 115
  • Taiwan
+886 02
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 19-1, Number 3 Yuan Qu Street
  • Nankang District
  • Taiepi, 115
  • Taiwan
+886 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fountain Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Fountain Biopharma‘s full profile, request access.

Request a free trial

Fountain Biopharma Patents

Fountain Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019085902-A1 Treating ige-mediated allergic diseases Inactive 31-Oct-2017
WO-2015145268-A2 Methods for producing recombinant glycoproteins with modified glycosylation Inactive 17-Mar-2014
WO-2015145268-A3 Methods for producing recombinant glycoproteins with modified glycosylation Inactive 17-Mar-2014
WO-2015145268-A8 Methods for producing recombinant glycoproteins with modified glycosylation Inactive 17-Mar-2014
JP-2017507664-A Process for producing recombinant glycoproteins having modified glycosylation Active 17-Mar-2014 C12P21/005
To view Fountain Biopharma’s complete patent history, request access »

Fountain Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fountain Biopharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Fountain Biopharma‘s full profile, request access.

Request a free trial

Fountain Biopharma Acquisitions (1)

Fountain Biopharma’s most recent deal was a Merger/Acquisition with Synovel Sciences. The deal was made on 01-Mar-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Synovel Sciences 01-Mar-2017 Merger/Acquisition Drug Discovery
To view Fountain Biopharma’s complete acquisitions history, request access »

Fountain Biopharma FAQs

  • When was Fountain Biopharma founded?

    Fountain Biopharma was founded in 2010.

  • Where is Fountain Biopharma headquartered?

    Fountain Biopharma is headquartered in Taiepi, Taiwan.

  • What is the size of Fountain Biopharma?

    Fountain Biopharma has 39 total employees.

  • What industry is Fountain Biopharma in?

    Fountain Biopharma’s primary industry is Drug Discovery.

  • Is Fountain Biopharma a private or public company?

    Fountain Biopharma is a Private company.

  • What is Fountain Biopharma’s current revenue?

    The current revenue for Fountain Biopharma is .

  • How much funding has Fountain Biopharma raised over time?

    Fountain Biopharma has raised $51.5M.

  • Who are Fountain Biopharma’s investors?

    Diamond Biofund has invested in Fountain Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process